Showing 1,821 - 1,840 results of 1,890 for search '"Type 2 diabetes"', query time: 0.10s Refine Results
  1. 1821

    Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism by Alice J. Kroker, John B. Bruning

    Published 2015-01-01
    “…While endogenous ligands of PPARγ include fatty acids and eicosanoids, synthetic full agonists of the receptor, including members of the thiazolidinedione (TZD) class, have been widely prescribed for the treatment of type II diabetes mellitus (T2DM). Unfortunately, the use of full agonists has been hampered by harsh side effects with some removed from the market in many countries. …”
    Get full text
    Article
  2. 1822

    Along for the Ride: Intrahepatic Cholangiocarcinoma with Concomitant LECT2 Amyloidosis by Phoenix D. Bell, Aaron R. Huber, Tom C. DeRoche

    Published 2020-01-01
    “…We present a case of a 69-year-old Hispanic male with a past medical history of type II diabetes mellitus who presented with a two-month history of abdominal pain. …”
    Get full text
    Article
  3. 1823

    Gender Differences in Metabolic Disorders and Related Diseases in Spontaneously Diabetic Torii-Leprfa Rats by Takeshi Ohta, Yoshiaki Katsuda, Katsuhiro Miyajima, Tomohiko Sasase, Shuichi Kimura, Bin Tong, Takahisa Yamada

    Published 2014-01-01
    “…The Spontaneously Diabetic Torii Leprfa (SDT fatty) rat is a novel type 2 diabetic model wherein both male and female rats develop glucose and lipid abnormalities from a young age. …”
    Get full text
    Article
  4. 1824

    Tribbles 3 Regulates the Fibrosis Cytokine TGF-β1 through ERK1/2-MAPK Signaling Pathway in Diabetic Nephropathy by Luwei Zhang, Jinhang Zhang, Xinnong Liu, Shengli Liu, Jun Tian

    Published 2014-01-01
    “…To reveal the expression and possible role of tribbles homolog 3 (TRB3) in the incidence of type 2 diabetic nephropathy, we used immunohistochemistry, real-time quantitative PCR, western blot analysis, and enzyme-linked immunosorbent assay (ELISA) to study the expression of TRB3, extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (ERK1/2 MAPK), transforming growth factor β1 (TGF-β1), and collagen type IV in kidneys of db/db diabetic mice and in murine renal mesangial cells stimulated with high glucose. …”
    Get full text
    Article
  5. 1825

    The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists by Tamotsu Tsukahara

    Published 2012-01-01
    “…In recent years, peroxisome proliferator-activated receptor gamma (PPARγ) has been reported to be a target for the treatment of type II diabetes. Furthermore, it has received attention for its therapeutic potential in many other human diseases, including atherosclerosis, obesity, and cancers. …”
    Get full text
    Article
  6. 1826

    Risk Factors for Microvascular Complications of Diabetes in a High-Risk Middle East Population by Sohaila Cheema, Patrick Maisonneuve, Mahmoud Zirie, Amin Jayyousi, Hekmat Alrouh, Amit Abraham, Sura Al-Samraye, Ziyad Mahfoud, Ibrahim Mohammed Al-Janahi, Buthaina Ibrahim, Albert B. Lowenfels, Ravinder Mamtani

    Published 2018-01-01
    “…We collected information via a structured questionnaire and directly from the patient’s record on 1034 adult type 2 diabetic patients who were attending outpatient clinics in Qatar. …”
    Get full text
    Article
  7. 1827

    A Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal Muscle by R. W. A. Mackenzie, P. Watt

    Published 2016-01-01
    “…In addition, hypoxic exposure has been shown to improve glucose control in type 2 diabetics. The literature surrounding hypoxia-induced changes to glycemic control appears to be confusing and conflicting. …”
    Get full text
    Article
  8. 1828

    Signaling Pathway Puts the Break on Fat Cell Formation by Ormond A. MacDougald

    Published 2001-01-01
    “…Unfortunately, excess fat or adipose tissue is associated with a wide array of health problems, including increased incidence of type II diabetes, cardiovascular disease, hypertension, sleep apnea, and skeletomuscular problems [4,5,6]. …”
    Get full text
    Article
  9. 1829

    Serum Fibroblast Growth Factor 21 Levels Are Correlated with the Severity of Diabetic Retinopathy by Yuan Lin, Ye-cheng Xiao, Hong Zhu, Qing-yan Xu, Lei Qi, Yu-bin Wang, Xiu-juan Li, Ma-li Zheng, Rui-sheng Zhong, Yi Zhang, Xiang-dong Xu, Bo-le Wu, Zhu-mei Xu, Xiang-hong Lu

    Published 2014-01-01
    “…The aim of the study was to assess serum fibroblast growth factor 21 (FGF21) concentrations in Chinese type 2 diabetic patients with and without retinopathy and to assess the association between FGF21 and the severity of retinopathy. 117 diabetic patients were compared with 68 healthy controls. …”
    Get full text
    Article
  10. 1830
  11. 1831

    Anti-diabetic effect of aloin via JNK-IRS1/PI3K pathways and regulation of gut microbiota by Ruting Zhong, Lanbin Chen, Yuanyuan Liu, Shouxia Xie, Sumei Li, Bin Liu, Chao Zhao

    Published 2022-01-01
    “…The insulin-resistant HepG2 (IR-HepG2) cell model and the type 2 diabetic (T2D) mouse model were successfully established using dexamethasone and a high-fat high-sucrose diet with low-dose streptozotocin, respectively. …”
    Get full text
    Article
  12. 1832

    Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists by Antonietta Bernardo, Luisa Minghetti

    Published 2008-01-01
    “…In the recent years, the peroxisome proliferator-activated receptor-𝛾 (PPAR-𝛾), a well known target for type II diabetes treatment, has received an increasing attention for its therapeutic potential in inflammatory and degenerative brain disorders. …”
    Get full text
    Article
  13. 1833

    The Association of Adiposity Indices and Plasma Vitamin D in Young Females in Saudi Arabia by Lubna Ibrahim Al Asoom

    Published 2016-01-01
    “…Some evidences indicate its association with metabolic syndrome, type II diabetes, and cardiovascular diseases. In the current study we aim to study the association of vitamin D level and indicators of adiposity in young Saudi females. …”
    Get full text
    Article
  14. 1834

    Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats by Eric P. Davidson, Lawrence J. Coppey, Hanna Shevalye, Alexander Obrosov, Mark A. Yorek

    Published 2018-01-01
    “…In this study, we wanted to extend our investigation of the efficacy of fish oil with or without salsalate on vascular and neural complications using a type 2 diabetic rat model. Four weeks after the onset of hyperglycemia, diabetic rats were treated via the diet with 3 different amounts of menhaden oil with or without salsalate for 12 weeks. …”
    Get full text
    Article
  15. 1835

    Reducing oxidative stress and hepatoprotective effect of water extracts from Pu-erh tea on rats with high-fat diet by Jingjing Su, Xueqing Wang, Wenjun Song, Xiaoli Bai, Changwen Li

    Published 2016-12-01
    “…Meanwhile, the extracts could increase the production of hepatic glycogen and the activity of PK, and reduce glucose level, protecting the liver from the diseases associated with type II diabetes.…”
    Get full text
    Article
  16. 1836

    Evaluation of the EndoPAT as a Tool to Assess Endothelial Function by M. Moerland, A. J. Kales, L. Schrier, M. G. J. van Dongen, D. Bradnock, J. Burggraaf

    Published 2012-01-01
    “…Endothelial function in renally impaired and type 2 diabetic patients was not decreased compared to healthy volunteers (2.9±1.4 and 1.8±0.3, resp., versus 1.8±0.5, P>0.05). …”
    Get full text
    Article
  17. 1837

    Influence of Duodenal–Jejunal Implantation on Glucose Dynamics: A Pilot Study Using Different Nonlinear Methods by David Cuesta-Frau, Daniel Novák, Vacláv Burda, Daniel Abasolo, Tricia Adjei, Manuel Varela, Borja Vargas, Milos Mraz, Petra Kavalkova, Marek Benes, Martin Haluzik

    Published 2019-01-01
    “…We hypothesized that DJBL also influences the glucose dynamics in type II diabetes, based on the induced changes already demonstrated in other physiological characteristics and parameters. …”
    Get full text
    Article
  18. 1838

    Proinflammatory Cytokine Expression in Apical Periodontitis from Diabetic Patients by Estéfano Borgo Sarmento, Rosana Helena Teixeira de Lima Ribeiro Andrade, Cinthya Cristina Gomes, Fábio Ramôa Pires, Maria Isabel Bastos Valente, Adalgiza Mafra Moreno, Marco Orsini, Dennis Carvalho Ferreira, Lucio Souza Gonçalves, Luciana Armada

    Published 2023-01-01
    “…Therefore, this study evaluated the immunoexpression of IL-1β, TNF-α, and IL-17 in apical periodontitis from type 2 diabetic patients through immunohistochemistry. …”
    Get full text
    Article
  19. 1839

    Atypical Presentation of Disseminated Zoster in a Patient with Rheumatoid Arthritis by Nirav Patel, Davinder Singh, Krunal Patel, Shadab Ahmed, Prachi Anand

    Published 2015-01-01
    “…Comorbidities include hypertension, type II diabetes, and dyslipidemia. Patient was on methotrexate 12.5 mg and was not receiving any corticosteroids, anti-TNF therapy, or other biological agents. …”
    Get full text
    Article
  20. 1840

    Insulin Therapy in Diabetic Hyperglycemic Emergencies by Diana Machado Ramírez, Manuel Licea Puig

    Published 2014-09-01
    “…<br /><strong>Results:</strong> diabetic ketoacidosis occurred in 57.5 % of the type 1 diabetic patients and in the 42.5 % of the type 2 diabetics. None of the type 1 diabetics developed hyperglycemic hyperosmolar nonketotic state and this complication was observed in 23.0 % of the patients with diabetes type 2. …”
    Get full text
    Article